ÂÜÀòÂÒÂ×

Chinweike (Chinwe) Ukomadu is a physician-scientist whose career spans academia, clinical care and industry. Chinwe earned his PhD (Physiology) and MD from Yale University School of Medicine and was an internal medicine resident and chief medical resident at Brigham and Women’s Hospital (BWH). He completed sub-specialty training in gastroenterology and a post-doctoral fellowship at BWH prior to joining the staff of the hospital and Harvard Medical School with roles as an independent investigator, clinician and educator. He also served as the director of the Summer Training in Academic Research and Scholarship (STARS) program for under-represented minority college and medical students at BWH.

After 21 years at BWH, Chinwe was recruited to Novartis Institutes For Biomedical Research (NIBR) and led the pre-clinical and translational strategy in gastroenterology and liver diseases at NIBR as well as providing translational medicine expertise for the entire liver pipeline across Novartis.

In 2021, Chinwe joined Takeda Pharmaceuticals, a multinational company as its Head of the GI Therapeutic Area Unit. He is responsible for the gastroenterology pipeline and strategy in research and development, and is a member of the Takeda Research and Development leadership team. Dr. Ukomadu serves on the board of a number of biotech companies.